2 terminated, 1 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow ViaCyte: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus VC-01 Combination Product - Type 1 Diabetes | Phase 1 / Phase 2 | Terminated | ViaCyte | 31 | 2019-06-25 | 2023-10-18 |
| A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness VC-02 Combination Product - Type 1 Diabetes Mellitus With Hypoglycemia | Phase 1 / Phase 2 | Completed | ViaCyte | 49 | 2017-07-06 | 2024-12-03 |
| A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus VC-01™ Combination Product - Type 1 Diabetes Mellitus | Phase 1 / Phase 2 | Terminated | ViaCyte | 19 | 2014-09-01 | 2022-03-24 |
United States (3) · Canada (2) · Belgium (1)
Gautham Marigowda (1) · Manasi Jaiman, MD (1)
PMID 29317381, PMID 29420708, PMID 34193595, PMID 34861146, PMID 35028608, PMID 38012450